Domestic pharmaceutical firms' advancement toward overseas market mired

Published: 2003-07-15 06:56:00

Updated: 2003-07-15 06:56:00

Despite the recent brisk movement towards foreign markets in the domestic pharmaceutical industry of Korea's pharmaceutical firms to foreign markets, there are mounting concerns that domestic pharmaceutical makers are facing a variety of huddles to block Korea's export drive of drugs due to insuf...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK